SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001214659-24-010057
Filing Date
2024-05-28
Accepted
2024-05-28 17:03:58
Documents
4
Period of Report
2024-05-24

Document Format Files

Seq Description Document Type Size
1 g5282416k.htm 6-K 15260
2 EXHIBIT 4.1 ex4_1.htm EX-4.1 124642
3 EXHIBIT 4.2 ex4_2.htm EX-4.2 124926
4 EXHBIT 4.3 ex4_3.htm EX-4.3 124522
  Complete submission text file 0001214659-24-010057.txt   390520
Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ
Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ 44 (0)1235 888300
Biodexa Pharmaceuticals Plc (Filer) CIK: 0001643918 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37652 | Film No.: 24992894
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)